Consensus American Well Corporation

Equities

AMWL

US03044L1052

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
0.528 USD -2.13% Intraday chart for American Well Corporation -3.40% -64.56%

Evolution of the average Target Price on American Well Corporation

Price target over the last 5 years

History of analyst recommendation changes

761e1814743f7423de.UaySDc3ArBYRq8iiOyKeAsE-nN6YK5hVGdcHQIUM_mY.KerneL2M31FBwqHMDXTvQaoKz-noTcokXL1NF8l7l1Mc3stOi6uUR0PIhQ~0b31abc87ad29bf79cdbf38d33c84a98
Morgan Stanley Adjusts American Well's Price Target to $1 From $1.75, Keeps Equalweight Rating MT
UBS Adjusts American Well Price Target to $1.30 From $2.60, Maintains Neutral Rating MT
UBS Adjusts Price Target on American Well to $2.60 From $2.80, Maintains Neutral Rating MT
Morgan Stanley Downgrades American Well to Equalweight From Overweight, Halves PT to $2.50 From $5, Cites Weaker-Than-Expected Growth MT
Credit Suisse Trims American Well's Price Target to $3.50 From $4 After Lower-Than-Expected Q1 Results, Keeps Neutral Rating MT
TD Cowen Downgrades American Well to Market Perform From Outperform, Adjusts Price Target to $2.50 From $5 MT
Morgan Stanley Adjusts Price Target on American Well to $5 From $6, Maintains Overweight Rating MT
UBS Adjusts American Well Price Target to $3.10 From $4.20, Maintains Neutral Rating MT
Piper Sandler Downgrades American Well to Neutral From Overweight, Adjusts Price Target to $3.50 From $5 MT
Credit Suisse Trims American Well's Price Target to $4 From $5 on Lower-Than-Expected 2023 Outlook, Keeps Neutral Rating MT
Morgan Stanley Cuts Price Target on American Well to $6 From $7, Reiterates Overweight Rating MT
BofA Securities Upgrades American Well to Buy From Neutral, Price Target is $4.20 MT
Truist Securities Starts American Well at Hold With $5 Price Target MT
Piper Sandler Adjusts American Well's Price Target to $5 From $6, Reiterates Overweight Rating MT
UBS Adjusts American Well Price Target to $4.20 From $3.25, Maintains Neutral Rating MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors MT
Piper Sandler Adjusts American Well's Price Target to $6 From $5, Maintains Overweight Rating MT
Goldman Sachs Adjusts Price Target for American Well to $4.50 From $5, Maintains Neutral Rating MT
Piper Sandler Adjusts American Well's Price Target to $5 From $7, Reiterates Overweight Rating MT
Morgan Stanley Lowers American Well's Price Target to $7 From $9, Maintains Overweight Rating MT
Guggenheim Initiates American Well With Buy Rating, $6 Price Target MT
UBS Adjusts American Well Price Target to $4 From $10, Maintains Neutral Rating MT
Wells Fargo Adjusts American Well's Price Target to $4 from $6, Keeps Equalweight Rating MT
Piper Sandler Adjusts American Well's Price Target to $7 From $12, Reiterates Overweight Rating MT
Credit Suisse Lowers American Well's Price Target to $8 from $11, Among Hedge Funds' Least Preferred Healthcare Information Technology Names Heading Into 2022 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
0.528 USD
Average target price
1.978 USD
Spread / Average Target
+274.58%
High Price Target
4 USD
Spread / Highest target
+657.58%
Low Price Target
1 USD
Spread / Lowest Target
+89.39%

Consensus detail

Consensus revision (last 18 months)

Analysts covering American Well Corporation

Morgan Stanley
UBS
Credit Suisse
TD Cowen
Piper Sandler
BofA Securities
Truist Securities
Goldman Sachs
Guggenheim
Wells Fargo Securities
Jefferies & Co.
Berenberg Bank
Cowen
Cantor Fitzgerald
KeyBanc Capital Markets
Needham & Co.
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. AMWL Stock
  4. Consensus American Well Corporation